Max India Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32

MAXIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.2%1-day move

₹168.00

prior close

₹171.71

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-2.7-3.3-3.5-3.5+1.2-4.0-5.9-6.5-4.8-4.8+0.1-3.6——

Up moveDown movePending

AI summary

Max India Limited has submitted its quarterly statement of fund utilization for the quarter ended March 31, 2026. The company confirms there is NO deviation or variation in the use of proceeds from its Rights Issue (Rs. 124.23 crore raised on May 23, 2025) and Preferential Issue (Rs. 40.17 crore received so far, out of total Rs. 80.35 crore from September 24, 2025). Funds are being deployed exactly as stated in the Letter of Offer dated April 25, 2025. CARE Ratings Limited is the monitoring agency for the Rights Issue. This is a routine regulatory compliance filing confirming proper use of investor capital.

Likely market impact

This filing is positive for shareholders as it confirms the company is deploying investor funds as promised, with no deviations or misuse. It indicates sound corporate governance and adherence to stated objectives.